Disruption of protein kinase A in mice enhances healthy aging

• Published in: PloS one 2009-06, Vol.4 (6), p.e5963-e5963
• Main Authors: Enns, Linda C, Morton, John F, Treuting, Piper R, Emond, Mary J, Wolf, Norman S, Dai, Dao-Fu, McKnight, G S, Rabinovitch, Peter S, Ladiges, Warren C
• Format: Article
• Language: English
• Subjects: Adipose tissue; Adipose Tissue - metabolism; Age; Aging; Aging (artificial); Animal tissues; Animals; Blood glucose; Body fat; Body mass; Body Weight; Brain; Cardiovascular disease; Cardiovascular Disorders/Heart Failure; Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit - genetics; Cyclic AMP-Dependent Protein Kinases - genetics; Cyclic AMP-Dependent Protein Kinases - physiology; Developmental Biology/Aging; Diabetes and Endocrinology/Obesity; Disruption; End of life; Evolutionary Biology/Genomics; Fatty liver; Female; Females; Genetics and Genomics/Gene Function; Genotype; Genotypes; Geriatrics; Gerontology; Heart diseases; Heart failure; House mouse; Insulin; Kidneys; Kinases; Lean body mass; Leptin - blood; Lesions; Life span; Liver; Longevity; Male; Males; Mammals; Medicine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Molecular Biology; Muscle function; Mutants; Mutation; Nature conservation; Nephrology/Tubulointerstitial Diseases; Nutrition/Obesity; Older people; Oncology; Pathology; Pathology/Histopathology; Pharmacology; Physiological aspects; Protein kinase A; Protein kinases; Proteins; Radiology and Medical Imaging/Echocardiography; Rodents; Sarcopenia; Sex Factors; Signal transduction; Yeast; Yeasts
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0005963

Mutations that cause a reduction in protein kinase A (PKA) activity have been shown to extend lifespan in yeast. Loss of function of mammalian RIIbeta, a regulatory subunit of PKA expressed in brain and adipose tissue, results in mice that are lean and insulin sensitive. It was therefore hypothesized that RIIB null (RIIbeta(-/-)) mice would express anti-aging phenotypes. We conducted lifespan studies using 40 mutant and 40 wild type (WT) littermates of equal gender numbers and found that both the median and maximum lifespans were significantly increased in mutant males compared to WT littermates. The median lifespan was increased from 884 days to 1005 days (p = 0.006 as determined by the log rank test) and the 80% lifespan (defined here as 80% deaths) was increased from 941 days to 1073 days (p = 0.004 as determined by the Wang-Allison test). There was no difference in either median or 80% lifespan in female genotypes. WT mice of both genders became increasingly obese with age, while mutant mice maintained their lean phenotype into old age. Adiposity was found to correlate with lifespan for males only. 50% of male mice between 30 and 35 g, corresponding to about 5% body fat, for either genotype lived over 1000 days. No male mouse outside of this weight range achieved this lifespan. During their last month of life, WT mice began losing weight (a total of 8% and 15% of body weight was lost for males and females, respectively), but RIIbeta(-/-) male mice maintained their lean body mass to end of life. This attenuation of decline was not seen in female mutant mice. Old male mutant mice were insulin sensitive throughout their life. Both genders showed modestly lower blood glucose levels in old mutants compared to WT. Male mutants were also resistant to age-induced fatty liver. Pathological assessment of tissues from end of life male mutant mice showed a decrease in tumor incidence, decreased severity of renal lesions, and a trend towards a decrease in age-related cardiac pathology. These findings help establish the highly conserved nature of PKA and suggest that disruption of PKA affects physiological mechanisms known to be associated with healthy aging.